Nw Sarcoma Foundation A Non-Profit Corporation

The foundation administers the jenna westerholm pediatric help$ fund, a financial assistance program for pediatric sarcoma patients undergoing treatment. Our service area includes the five-state region of washington, oregon, alaska, montana, and idaho. During 2024, grants were made to 58 patients.

Outreach programs are patient activities intended to provide support, social and/or educational opportunities. Activities include casual chats for patients, survivors and caregivers. The foundation makes regular contact with sarcoma patients through the help$ programs, inviting them to our groups and other programming. The foundation organizes and sponsors sarcoma journal club meetings attended by sarcoma physicians and researchers in which latest treatments or research are discussed. Sarcoma physicians provide educational opportunities to anyone interested in ongoing research around various sarcomas, through researcher update nights. Patient education nights are led by topic experts to support patients and their families during different parts of their cancer journey. Community fun events are for sarcoma patients, survivors and caregivers to enjoy a fun activity while meeting others in the sarcoma community. Dragonslayer days provide a day of activities in local hospitals for pediatric patients and their families.

Care packages are provided to any sarcoma patient or anyone who has lost someone to sarcoma in our region. Packages provide a sense of hope and understanding that the patient and/or loved one of a sarcoma angel has a community that cares. Each package includes various items that assist a patient during treatment along with introductions about our organization and programs we host.

The foundation supports research organizations with grants aimed at advancing the capacity and prospects for sarcoma treatment research. We build capacity by increasing the number of sarcoma samples in tissue banks and adavance treatment prosepcts by supporting labs successful in bringing sarcoma treatments to trial.